Murad Chia Jei Biotechnology Co. Ltd. said its normalized net income for the third quarter was 13 Taiwan cents per share, an increase from 6 cents per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$10.6 million, an increase from NT$5.2 million in the prior-year period.

The normalized profit margin rose to 5.6% from 3.3% in the year-earlier period.

Total revenue grew 19.2% on an annual basis to NT$190.5 million from NT$159.7 million, and total operating expenses totaled NT$161.8 million, compared with NT$160.6 million in the year-earlier period.

Reported net income rose 12.0% year over year to NT$7.4 million, or 9 cents per share, from NT$6.6 million, or 8 cents per share.

As of Nov. 16, US$1 was equivalent to NT$32.83.